$TPIA News
Last published 4y ago
- 4y agoEHVVFTPIAEhave Issues Shareholder Letter and Provides Corporate UpdateGlobeNewswireMIAMI, Jan. 31, 2022 (GLOBE NEWSWIRE) -- Ehave, Inc., (OTC:EHVVF) (the "Company"), a provider of digital therapeutics for the psychedelic and mental health sectors, today issued a letter to shareholders from its Chief Executive Officer, Ben Kaplan.
- 4y agoTPIAMycotopia Therapies Announces Ei.Ventures Acquires 12x12 Estate in The Sandbox in Anticipation of PSLY.COM Launch Post-Merger with Mycotopia Therapies in Q1 2022GlobeNewswireMIAMI, Jan. 06, 2022 (GLOBE NEWSWIRE) -- Mycotopia Therapies Inc. (OTC:TPIA) (the "Company"), a biopharma company focused on research, technology, and the development of medical psychedelics, announced today Ei.Ventures has acquired a 12x 12 estate in
- 4y agoEHVVFTPIAEhave Plans Stock Distribution; Mycotopia Therapies Plans To Merge With Ei. VenturesGlobeNewswireMycotopia and Ei.Ventures announced the signing of an LOI to explore a merger and the formation of PSLY.COM, a $360 Million transaction, and will apply to list shares on NASDAQ; Ehave plans to spin out 30% MIAMI, Dec. 08, 2021 (GLOBE NEWSWIRE) -- Eh
- 4y agoTPIAMycotopia and Ei.Ventures sign LOI to Explore Merger and Formation of PSLY.COM, a $360 Million Transaction, And Will Apply To List Shares On NASDAQGlobeNewswireMIAMI, Dec. 07, 2021 (GLOBE NEWSWIRE) -- Mycotopia Therapies Inc. (OTC:TPIA) (the "Company"), a biopharma company focused on research, technology, and the development of medical psychedelics, announced today it has entered into a letter of intent regar
- 4y agoHAVLFTPIAMycotopia Therapies Announces Plan to Develop Psychedelic Sublingual Tablet to Help Treat DepressionGlobeNewswireMIAMI, Nov. 17, 2021 (GLOBE NEWSWIRE) -- Mycotopia Therapies Inc. (OTC:TPIA) (the "Company"), a biopharma company focused on research, technology, and the development of medical psychedelics, announced today it has initiated plans for a psilocybin-base
- 5y agoTPIAMycotopia Therapies Appoints Experienced Mental Health Professional Senator Dr. Saphire Longmore M.B.B.S., DM As Chief Medical Officer Of Caribbean AffairsGlobeNewswireMIAMI, Nov. 10, 2021 (GLOBE NEWSWIRE) -- Mycotopia Therapies Inc. (OTC:TPIA) (the "Company") today announced the appointment of Saphire Longmore M.B.B.S., DM, to the role of Chief Medical Officer of Caribbean Affairs. Sen Dr. Longmore's extensive caree
- 5y agoHAVLFTPIAMycotopia Therapies Issues CEO Letter to Stockholders, Reports on Significant Progress and Outlook for 2021GlobeNewswireMIAMI, Nov. 04, 2021 (GLOBE NEWSWIRE) -- Mycotopia Therapies Inc., (OTC:TPIA) (the "Company"), announced today that Ben Kaplan, President, Chief Executive Officer and Chairman, has issued a letter to Mycotopia Therapies' stockholders. The full text is
- 5y agoHAVLFTPIAHAVN Life Signs Agreement to Supply Psilocybin for Mycotopia TherapiesACCESS NewswireThe partnership will further industry growth for naturally derived psilocybin VANCOUVER, BC / ACCESSWIRE / August 25, 2021 / Havn Life Sciences Inc. (CSE:HAVN)(OTC:HAVLF)(FSE:5NP) (the "Company" or "Havn Life") a biotechnology company pursuing standardi
- 5y agoHAVLFTPIAMycotopia Therapies Signs Agreement With Havn Life Sciences For Purchase of Psilocybin SPPGlobeNewswireMIAMI, Aug. 25, 2021 (GLOBE NEWSWIRE) -- Mycotopia Therapies, Inc. (OTC:TPIA) (the "Company"), a company focused on psychedelic therapies, announced today it has entered into a Psilocybin Supply Agreement with Havn Life Sciences (CSE:HAVN) (OTC:HAVLF).
- 5y agoTPIAPsytech To Merge With Wesana; Mycotopia Shareholders Will Benefit From The TransactionsGlobeNewswireMIAMI, July 14, 2021 (GLOBE NEWSWIRE) -- Mycotopia Therapies, Inc., (OTC:TPIA) ("Mycotopia" or the "Company") announced today that on July 13, 2021 Wesana Health Holdings Inc. ("Wesana") (CSE:WESA) announced the execution of a definitive agreement to a
- 5y agoTPIAMycotopia Therapies PsyTech Inc. Announces Third Annual Psytech Summit on July 19th and 20th, 2021GlobeNewswireMIAMI, July 02, 2021 (GLOBE NEWSWIRE) -- Mycotopia Therapies, Inc., (OTC:TPIA) (the "Company") announced today an upcoming complimentary Psychedelic Industry summit will take place virtually on July 19-20 for investors and interested individuals. The t